Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Blasczyk

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Journal of Translational Medicine|July 23, 2015
Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantationBala Sai Sundarasetty, Stephan Kloess, Olaf Oberschmidt, et al.
Science Translational Medicine|July 17, 2024
Knockdown of swine leukocyte antigen expression in porcine lung transplants enables graft survival without immunosuppressionConstanca Figueiredo, Chen Chen-Wacker, Jawad Salman, et al.
Frontiers in Immunology|July 13, 2018
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative DiseaseRebecca E Schultze-Florey, Sabine Tischer, Leonie Kuhlmann, et al.
Journal for Immunotherapy of Cancer|October 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferationAnna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, et al.
Transplantation|December 30, 2015
IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung TransplantationFabio Ius, Wiebke Sommer, Daniela Kieneke, et al.
Ebiomedicine|July 11, 2020
Reappearance of effector T cells is associated with recovery from COVID-19Ivan Odak, Joana Barros-Martins, Berislav Bošnjak, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2021
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing AntibodiesSixten Körper, Bernd Jahrsdörfer, Victor M Corman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 15, 2022
Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocolWiebke Sommer, Murat Avsar, Khalil Aburahma, et al.
HLA|June 26, 2024
Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunityMaria Michela Santamorena, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
Human Gene Therapy Methods|March 21, 2012
Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapyMudita Pincha, Bala Sai Sundarasetty, Gustavo Salguero, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Journal of Translational Medicine|July 23, 2015
Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantationBala Sai Sundarasetty, Stephan Kloess, Olaf Oberschmidt, et al.
Science Translational Medicine|July 17, 2024
Knockdown of swine leukocyte antigen expression in porcine lung transplants enables graft survival without immunosuppressionConstanca Figueiredo, Chen Chen-Wacker, Jawad Salman, et al.
Frontiers in Immunology|July 13, 2018
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative DiseaseRebecca E Schultze-Florey, Sabine Tischer, Leonie Kuhlmann, et al.
Journal for Immunotherapy of Cancer|October 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferationAnna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, et al.
Transplantation|December 30, 2015
IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung TransplantationFabio Ius, Wiebke Sommer, Daniela Kieneke, et al.
Ebiomedicine|July 11, 2020
Reappearance of effector T cells is associated with recovery from COVID-19Ivan Odak, Joana Barros-Martins, Berislav Bošnjak, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2021
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing AntibodiesSixten Körper, Bernd Jahrsdörfer, Victor M Corman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 15, 2022
Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocolWiebke Sommer, Murat Avsar, Khalil Aburahma, et al.
HLA|June 26, 2024
Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunityMaria Michela Santamorena, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
Human Gene Therapy Methods|March 21, 2012
Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapyMudita Pincha, Bala Sai Sundarasetty, Gustavo Salguero, et al.
Pageof 21